Fifth Third Bancorp’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Fifth Third Bancorp’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-300	Closed	-$1K	–	2364
2019 Q4	$1K	Hold	300	–	–	﹤0.01%	2188
2019 Q3	$1K	Hold	300	–	–	﹤0.01%	2145
2019 Q2	$2K	Hold	300	–	–	﹤0.01%	2173
2019 Q1	$4K	Hold	300	–	–	﹤0.01%	1993
2018 Q4	$3K	Hold	300	–	–	﹤0.01%	2083
2018 Q3	$4K	Hold	300	–	–	﹤0.01%	2042
2018 Q2	$5K	Hold	300	–	–	﹤0.01%	2066
2018 Q1	$5K	Hold	300	–	–	﹤0.01%	2070
2017 Q4	$7K	Hold	300	–	–	﹤0.01%	1938
2017 Q3	$12K	Hold	300	–	–	﹤0.01%	1740
2017 Q2	$9K	Hold	300	–	–	﹤0.01%	1775
2017 Q1	$11K	Hold	300	–	–	﹤0.01%	1711
2016 Q4	$15K	Hold	300	–	–	﹤0.01%	1692
2016 Q3	$16K	Hold	300	–	–	﹤0.01%	1702
2016 Q2	$12K	Hold	300	–	–	﹤0.01%	1756
2016 Q1	$12K	Sell	300 -200	-40%	-$6.87K	﹤0.01%	1806
2015 Q4	$21K	Hold	500	–	–	﹤0.01%	1679
2015 Q3	$8K	Hold	500	–	–	﹤0.01%	2130
2015 Q2	$12K	Hold	500	–	–	﹤0.01%	2024
2015 Q1	$11K	Hold	500	–	–	﹤0.01%	1986
2014 Q4	$14K	Buy	+500	New	+$8.61K	﹤0.01%	1844

Other funds holding FPRX

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Fifth Third Bancorp's FPRX Position: Q1 2020 in Review

Fifth Third Bancorp sold out of Five Prime Therapeutics, Inc. (FPRX) in Q1 2020, closing a stake of 300 shares — an estimated $1K sold.

Fifth Third Bancorp first reported a position in FPRX in Q4 2014 and held it in 21 quarters. The position peaked at $21K in Q4 2015. 87 funds tracked by Wall St. Rank hold FPRX as of Q1 2020.

Fifth Third Bancorp reported no remaining Five Prime Therapeutics, Inc. position as of Q1 2020 after selling out during the quarter.
Fifth Third Bancorp sold 300 Five Prime Therapeutics, Inc. shares in Q1 2020, an estimated $1K.
Fifth Third Bancorp first reported a position in Five Prime Therapeutics, Inc. in Q4 2014 and held it in 21 quarters.
Fifth Third Bancorp's Five Prime Therapeutics, Inc. position peaked at $21K in Q4 2015.
87 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q1 2020.

Based on Fifth Third Bancorp's 13F filing for Q1 2020, filed 5 May 2020.